Cargando…

Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease

Background: Cerebrospinal fluid (CSF) platelet‐derived growth factor receptor‐β (PDGFRβ) has been proposed as a biomarker of blood–brain barrier (BBB) breakdown. We studied PDGFRβ levels as a biomarker for cerebral amyloid angiopathy (CAA), amnestic mild cognitive impairment (aMCI), or Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Kort, Anna M., Kuiperij, H. Bea, Kersten, Iris, Versleijen, Alexandra A.M., Schreuder, Floris H.B.M., Van Nostrand, William E., Greenberg, Steven M., Klijn, Catharina J.M., Claassen, Jurgen A.H.R., Verbeek, Marcel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787758/ https://www.ncbi.nlm.nih.gov/pubmed/34874603 http://dx.doi.org/10.1002/alz.12506

Ejemplares similares

Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis
por: Jäkel, Lieke, et al.
Publicado: (2021)

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: van den Berg, Emma, et al.
Publicado: (2023)

Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
por: Vervuurt, Marc, et al.
Publicado: (2023)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage
por: Jäkel, Lieke, et al.
Publicado: (2020)

MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy
por: Marazuela, Paula, et al.
Publicado: (2021)

Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome
por: Kaushik, Kanishk, et al.
Publicado: (2023)

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
por: Müller, Mareike, et al.
Publicado: (2015)

Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42
por: Jäkel, Lieke, et al.
Publicado: (2020)

Views on the Desirability of Diagnosing Sporadic Cerebral Amyloid Angiopathy with Biological Evidence
por: Abdulrahman, Herrer, et al.
Publicado: (2022)

Valuing biomarker diagnostics for dementia care: enhancing the reflection of patients, their care-givers and members of the wider public
por: van der Burg, Simone, et al.
Publicado: (2019)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Long-term prognosis after intracerebral haemorrhage
por: van Nieuwenhuizen, Koen M, et al.
Publicado: (2020)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2020)

Variation in medical management and neurosurgical treatment of patients with supratentorial spontaneous intracerebral haemorrhage
por: Sondag, Lotte, et al.
Publicado: (2021)

The association between perihaematomal oedema and functional outcome after spontaneous intracerebral haemorrhage: A systematic review and meta-analysis
por: Cliteur, Maaike P, et al.
Publicado: (2023)

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018)

A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example
por: Herbert, Megan K., et al.
Publicado: (2015)

Association between circulating inflammatory biomarkers and functional outcome or perihaematomal oedema after ICH: a systematic review & meta-analysis
por: Kirby, Caoimhe, et al.
Publicado: (2023)

Safety and technical efficacy of early minimally invasive endoscopy-guided surgery for intracerebral haemorrhage: the Dutch Intracerebral haemorrhage Surgery Trial pilot study
por: Sondag, Lotte, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy
por: Sembill, Jochen A, et al.
Publicado: (2023)

Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
por: Banerjee, Gargi, et al.
Publicado: (2021)

Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats
por: Zhu, Xiaoyue, et al.
Publicado: (2020)

White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
por: van Waalwijk van Doorn, Linda J.C., et al.
Publicado: (2021)

Cerebral Amyloid Angiopathy: A Systematic Review
por: Biffi, Alessandro, et al.
Publicado: (2011)

Differences in cerebral small vessel disease magnetic resonance imaging markers between lacunar stroke and non–Lobar intracerebral hemorrhage
por: Wiegertjes, Kim, et al.
Publicado: (2021)

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier
por: Biemans, Elisanne A.L.M., et al.
Publicado: (2016)

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
por: Delaby, Constance, et al.
Publicado: (2021)

The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
por: Banerjee, Gargi, et al.
Publicado: (2017)

Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy
por: Schurgers, Geert, et al.
Publicado: (2021)

Contrast leakage distant from the hematoma in patients with spontaneous ICH: A 7 T MRI study
por: Jolink, Wilmar MT, et al.
Publicado: (2019)

Neurosurgical Intervention for Supratentorial Intracerebral Hemorrhage
por: Sondag, Lotte, et al.
Publicado: (2020)

Effects of cerebral amyloid angiopathy on the brain vasculome
por: Deng, Wenjun, et al.
Publicado: (2022)

Treatment of the neurogenic bladder in spina bifida
por: de Jong, Tom P. V. M., et al.
Publicado: (2008)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial
por: Voigt, S., et al.
Publicado: (2023)

Hereditary cerebral amyloid angiopathy, Piedmont-type mutation
por: Kozberg, Mariel G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ol3k6lik90mpfhj8goksjl94ak